Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02794012 · ClinicalTrials.gov registry record
Periodontal Inflammation and Immunity in Preclinical Rheumatoid Arthritis
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 146
- Enrollment target
NCT02794012: Completed study, sponsored by University of Colorado, Denver.
NCT02794012 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 146 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02794012 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 146 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the association of Rheumatoid Arthritis (RA)-related antibodies and periodontal inflammation in subjects at-risk for Rheumatoid Arthritis. Subjects will undergo periodontal and joint examinations, as well as collection of body fluids to measure Rheumatoid Arthritis-related antibodies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-12 |
What the finished NCT02794012 record still lists
NCT02794012 is an observational study that tracks outcomes without assigning an intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02794012 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02794012 about?
NCT02794012 is a clinical study titled "Periodontal Inflammation and Immunity in Preclinical Rheumatoid Arthritis". The purpose of this study is to evaluate the association of Rheumatoid Arthritis (RA)-related antibodies and periodontal inflammation in subjects at-risk for Rheumatoid Arthritis. Subjects will undergo periodontal and joint examinations, as well as collection of body fluids to measure Rheumatoid Art...
What is the current status of trial NCT02794012?
This trial is currently completed. The enrollment target is 146 participants. The study started on 2016-07. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT02794012?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia